atorvastatin has been researched along with Aortic Valve Disease 1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aibibula, A; Shabiti, A; Tuerxun, A; Wufuer, H | 1 |
| Armstrong, ZB; Boughner, DR; Carruthers, CP; Drangova, M; Rogers, KA | 1 |
| Gao, X; Gu, G; Hu, W; Jin, S; Li, J; Li, Y; Wu, PH; Zhan, C; Zhang, L | 1 |
3 other study(ies) available for atorvastatin and Aortic Valve Disease 1
| Article | Year |
|---|---|
Therapeutic Effect and Mechanism of Action of Abnormal Savda Munziq in Development of Degenerative Atherosclerotic Aortic Valve Disease.
Topics: Animals; Aortic Valve; Aortic Valve Stenosis; Atherosclerosis; Atorvastatin; Bicuspid Aortic Valve Disease; Calcinosis; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diet, High-Fat; Drugs, Chinese Herbal; Heart Defects, Congenital; Heart Valve Diseases; Male; Medicine, Traditional; Plant Extracts; Rabbits; Triglycerides | 2017 |
Effects of an angiotensin II type 1 receptor blocker on aortic valve sclerosis in a preclinical model.
Topics: Angiotensin Receptor Antagonists; Animals; Aortic Valve; Atorvastatin; Bicuspid Aortic Valve Disease; Disease Progression; Heart Defects, Congenital; Heart Valve Diseases; Heptanoic Acids; Imidazoles; Immunohistochemistry; Male; Pyrroles; Rabbits; Random Allocation; Sclerosis; Tetrazoles | 2014 |
The effect of oxLDL on aortic valve calcification via the Wnt/ β-catenin signaling pathway: an important molecular mechanism.
Topics: Animals; Aortic Valve; Apoptosis; Atorvastatin; Bicuspid Aortic Valve Disease; Blotting, Western; Calcinosis; Cells, Cultured; Heart Defects, Congenital; Heart Valve Diseases; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Myofibroblasts; Pyrroles; Swine; Wnt Signaling Pathway | 2015 |